Barclays Maintains Equal-Weight on CME Group, Raises Price Target to $281
Barclays analyst Benjamin Budish maintains CME Group (NASDAQ:CME) with a Equal-Weight and raises the price target from $270 to $281.
Stocks · News reference
'Kalshi Tops $4B In Annualized Revenue as it Seeks $40B Valuation'- The Information
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Marex announces changes to Group Board
Marex Group Limited announced that Chair Robert Pickering has stepped down after a three-year tenure that oversaw the company's transformation from a private firm to a NASDAQ-listed business with over $5 billion market capitalization. John Pietrowicz, former CFO of CME Group, has been appointed as the new Chair. The leadership transition comes as Marex continues its growth trajectory following its successful IPO in April 2024.
UBS Maintains Neutral on CME Group, Raises Price Target to $270
UBS analyst Alex Kramm maintains CME Group (NASDAQ:CME) with a Neutral and raises the price target from $260 to $270.
TD Cowen Maintains Buy on CME Group, Raises Price Target to $300
TD Cowen analyst Bill Katz maintains CME Group (NASDAQ:CME) with a Buy and raises the price target from $292 to $300.
Eric Trump Says Crypto Can 'Declare Victory' Over Banks: Is He Right?
Eric Trump says crypto has beaten big banks as adoption grows, while AI and tokenization drive the industry’s next phase.
Barclays Maintains Underweight on Coinbase Global, Raises Price Target to $149
Barclays analyst Benjamin Budish maintains Coinbase Global (NASDAQ:COIN) with a Underweight and raises the price target from $95 to $149.